Dr Shobhit Baijal is a Consultant Medical Oncologist based at The University Hospitals Birmingham NHS Trust where he actively treats lung and colorectal cancer patients. He specialises in all forms of cancer drug treatment including chemotherapy, immuno-oncology, precision oncology and chemo-embolisation.

Dr Baijal has a large clinical trial portfolio and is UK Chief Investigator and Principle Investigator for national and international clinical trials. He has numerous publications and regularly presents at regional, national and international cancer meetings. He is on the BTOG Steering Committee and also sits on the Roy Castle Lung Cancer Foundation advisory panel.

He is heavily involved with cancer pathway optimisation and re-design both at a Trust and Cancer Alliance level, where he has already implemented practice changing innovations.